2021 Managed Healthcare Executive® Pharmacy Survey: Lasting Effects of the Pandemic
In this part two series, participants give their opinions on the lasting effects of the pandemic. MHE's annual pharmacy survey had over 225 respondents. We will be posting the results over the next several days.
The pandemic flipped the switch on telehealth and at-home care, and the respondents to our annual Pharmacy Survey see them as having staying power. A quarter of the respondents said the increased use of telehealth will be the most important, lasting effect of the pandemic on the U.S. healthcare system and 35% put at-home care of all kinds in that category. Although many experts see the pandemic as accelerating the adoption of value-based payment, only 4% of our respondents ranked that as the pandemic’s most important lasting effect.
Not surprisingly, an increase in research and development on infectious disease got the most votes for the important, lasting effect on the pharmaceutical sector.
The online survey was conducted from April 5 through May 10.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
FDA Clears Phase 2 Trial of Cannabis in PTSD
November 20th 2024After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.
Read More
